Published at 11/06/2021 at 17:02
Published at 11/06/2021 at 16:43
Published at 11/06/2021 at 08:24
Published at 11/06/2021 at 08:19
Published at 11/06/2021 at 07:39
Published at 11/06/2021 at 06:06
Published at 10/06/2021 at 17:20
Published at 10/06/2021 at 17:16
Published at 10/06/2021 at 08:32
Published at 10/06/2021 at 08:09
Published at 11/06/2021 at 20:05
Published at 11/06/2021 at 15:53
Published at 11/06/2021 at 12:07
Published at 11/06/2021 at 09:10
Published at 11/06/2021 at 06:58
Published at 11/06/2021 at 02:25
Published at 10/06/2021 at 20:25
Published at 10/06/2021 at 15:27
FOREX-Dollar hovers above 5-month low, FX volatility drops further ahead of ECB, U.S. inflation dataPublished at 10/06/2021 at 11:46
Published at 10/06/2021 at 08:40
Published at 11/06/2021 at 20:21
Published at 11/06/2021 at 19:13
Published at 11/06/2021 at 14:31
Published at 11/06/2021 at 08:20
Published at 11/06/2021 at 03:11
Published at 11/06/2021 at 02:30
Published at 10/06/2021 at 20:22
Published at 10/06/2021 at 19:11
Published at 10/06/2021 at 12:56
Published at 10/06/2021 at 08:19
UPDATE 1-AstraZeneca lifts FTSE 100 from Barclays slump
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)
* AstraZeneca tops FTSE 100 on earnings beat
* Smurfit Kappa rises on Q1 result
* Barclays slumps , cautious outlook weighs
* FTSE 100 up 0.1%, rises 3.8% in April
(Releads, adds closing prices, comments)
By Devik Jain and Julien Ponthus
April 30 (Reuters) - London's FTSE 100 index outshone its European rivals on Friday, boosted by earnings updates from AstraZeneca and Smurfit Kappa which help offset a slump in Barclays shares due to a cautious outlook despite profits beating expectations.
London's blue chip index ended the session up 0.1% to secure a monthly gain of about 3.8%, the most since November, and bring a year-to-date rise to almost 8%.
The last day of trading in April saw U.S. and European benchmarks edge lower after reaching record highs this week on the back of an upbeat first-quarter earnings season.
The pan-European STOXX 600 ticked down 0.3% while on Wall Street the S&P 500 fell 0.6% in afternoon trading.
The star performer in London was heavyweight AstraZeneca
as better-than-expected results and a second half growth forecast lifted its shares 4.3% and buoyed the broader UK market.
The drugmaker said its COVID-19 vaccine sales were $275 million in the first-quarter and that it was on track to deliver 200 million doses a month from April.
"Despite the intense operational and political challenges created by AZN’s COVID-19 vaccine roll out, the core business continues to perform above market expectations in a most challenging quarter, demonstrating strength across therapeutic areas and geographies," Citigroup analysts said in a note.
Another big winner on Friday was Smurfit Kappa . Europe's largest paper packaging producer jumped 4.2% after it posted a 6% increase in first-quarter revenue on strong packaging demand.
The index was further supported by tobacco makers British American Tobacco and Imperial Brands which rose more than 2% each after peer Swedish Match reported upbeat quarterly profit.
Barclays posted by far the worst performance of the session, losing 7% despite beating expectations with January-March profit more than doubling to 2.4 billion pounds.
"A drop in investment banking earnings, lower revenues and a cautious outlook took the shine off a doubling in profits," wrote Markets.com analyst Neil Wilson.
Though the equities trading business heavily outperformed, analysts highlighted the 35% drop in revenues from its fixed income, currencies and commodities, which was largely linked to tighter spreads and lower client activity.
The domestically focused midcap FTSE 250 index advanced 0.5%.
After the U.S. Federal Reserve maintained a status quo on its monetary policy on Wednesday, investors' focus has now turned towards Bank of England's meeting on May 6 where it might
ease its foot off the stimulus pedal and slow bond purchases as Britain's economy rebounds.
In February, the BoE forecast the economy would grow 5% this year after slumping by almost 10% in 2020.
"The combination of a shallower Q1 contraction, faster exit from lockdown, a more supportive near-term fiscal policy, and a better external backdrop should see the Bank push up its 2021 projections closer to 7% from 5%," wrote Deutsche Bank economist Sanjay Raja in a note.
"An inevitable growth upgrade would give the monetary policy committee (MPC) enough ammunition to start QE taper."
Among other stocks, cybersecurity company Darktrace soared 32% in its trading debut.
(Reporting by Devik Jain in Bengaluru and Julien Ponthus in London; editing by Uttaresh.V, Kirsten Donovan)
((Devik.Jain@thomsonreuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 6182 2062; ;))
(( For related prices, Reuters users may click on - *
UK stock report
techMARK 100 index: FTSE futures:
Gilt futures: Smallcap index:
FTSE 250 index: FTSE 350 index:
Market digest: Top 10 by vol:
Top price gainers: Top % gainers:
Top price losers: Top % losers:
* For related news, click on - *
UK hot stocks: and Wall Street:
Gilts report: Euro bond report
Pan European stock report:
Tokyo stocks: HK stocks:
Sterling report: Dollar report:
* For company prices, click on - *
Company directory: By sector:
* For pan-European market data, click on - *
European Equities speed guide................
FTSE Eurotop 300 index...........................
DJ STOXX index...................................
Top 10 STOXX sectors........................
Top 10 EUROSTOXX sectors...................
Top 10 Eurotop 300 sectors..................
Top 25 European pct gainers....................
Top 25 European pct losers..................... ))